Other languages Instil Bio, Inc.

Equities

TIL

US45783C2008

Market Closed - Nasdaq Other stock markets 03:19:02 2024-05-23 pm EDT			5-day change	1st Jan Change
11.24 ^USD	+0.18%		-4.75%	+47.51%

May. 13	Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating	MT
May. 10	Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10
Instil Bio, Inc. Announces Board Changes	Apr. 26
Instil Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21
Instil Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21
Instil Bio, Inc. Enters into Agreement with A Collaboration to Conduct Preclinical Manufacturing Feasibility Studies in the ITIL-306 Program	Jan. 16
Instil Bio, Inc. Announces the Closure of Its UK Manufacturing and Clinical Operations	Jan. 16
Instil Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Instil Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Instil Bio, Inc. Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference	23-06-26
Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Instil Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Instil Bio Announces Resumption of Clinical Trial of Costar-Til Candidate Itil-306 in Lung, Ovarian, and Renal Cancer	23-01-09
Top Midday Decliners	22-12-08
Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday	22-12-08
Instill Bio to Cut US Workforce by 60%; Reprioritizes Clinical Program; Shares Down Pre-Bell	22-12-08
Instil Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Instil Bio, Inc. Announces Executive Changes	22-11-14
Sector Update: Healthcare Stocks Posting Small Declines in Late Trade	22-10-31
Sector Update: Health Care	22-10-31
Sector Update: Health Care Stocks Decline Premarket Monday	22-10-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Instil Bio, Inc.

Equities

TIL

US45783C2008

Other languages

Filters